Mumbai-headquartered specialty-chemicals manufacturer making chlorinated phenols, hydrogenation and ammonolysis derivatives (PCP, PNA, PAP, Ortho/Para Anisidine) for dyes, pigments, agrochemicals and pharma customers
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 12 | 27 | 27 | 27 | 28 | 28 | 28 | 28 |
| Reserves | 374 | 475 | 576 | 638 | 637 | 634 | 647 | 669 |
| Borrowings | 119 | 150 | 306 | 220 | 216 | 212 | 199 | 219 |
| Other Liabilities | 125 | 154 | 174 | 220 | 262 | 206 | 187 | 215 |
| Total Liabilities | 629 | 806 | 1.1k | 1.1k | 1.1k | 1.1k | 1.1k | 1.1k |
| AssetsFixed Assets | 256 | 478 | 509 | 610 | 630 | 644 | 695 | 683 |
| CWIP | 129 | 46 | 110 | 70 | 86 | 66 | 9 | 21 |
| Investments | 34 | 42 | 53 | 53 | 54 | 54 | 64 | 64 |
| Other Assets | 210 | 240 | 410 | 373 | 371 | 315 | 294 | 364 |
| Total Assets | 629 | 806 | 1.1k | 1.1k | 1.1k | 1.1k | 1.1k | 1.1k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 77 | 160 | 115 | -11 | 183 | 85 | 59 | 44 |
| Cash from Investing | -88 | -191 | -135 | -120 | -91 | -65 | -27 | -39 |
| Cash from Financing | 2 | 35 | 22 | 146 | -109 | -23 | -28 | -11 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -6 | -42 | -37 | -126 | 96 | 20 | 29 | 11 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
VALIANTORG · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.